Macrophage differentiation and activation

Macrophage differentiation and activation encompasses the complex biological processes by which monocytes differentiate into macrophages and subsequently adopt specific functional phenotypes in response to microenvironmental signals[1][7]. This process involves extensive molecular reprogramming rather than activation of a single target. The differentiation process is characterized by multiple molecular changes including increased expression of cleavage/polyadenylation machinery proteins, altered poly(A) site usage, cell cycle exit, increased cell adhesion, acquisition of structural complexity, and morphological changes[1]. Key regulatory proteins include CstF64, Fip1, and components of the core mRNA processing machinery[1]. Macrophage activation is typically classified into M1 (classically activated) and M2 (alternatively activated) phenotypes[7][10]. M1 macrophages are induced by IFN-γ, LPS, and TNF-α through pathways including TLR4/MyD88/NF-κB, JAK/STAT1, and MAPK signaling[4][7]. They exhibit pro-inflammatory properties, produce cytokines like TNF-α, IL-1β, and IL-12, and mediate defense against bacterial pathogens[4][10]. M2 macrophages are induced by IL-4, IL-10, and TGF-β through PI3K/AKT and STAT6 pathways[3][9]. They are associated with tissue repair, wound healing, and parasite infections, expressing markers like Arg1, Retnla, and Chi3l3[10]. The process involves numerous signaling pathways including NF-κB, MAPK (ERK, JNK, P38), JAK/STAT, PI3K/AKT, mTOR, PKC, and metabolic reprogramming involving glycolysis and oxidative phosphorylation[2][3][4][6]. Growth factors GM-CSF and M-CSF play critical roles in determining macrophage functional phenotypes[3][4]. This is a coordinated biological process rather than a discrete molecular target suitable for therapeutic intervention.

Other names

Macrophage polarizationM1/M2 macrophage activationClassical and alternative macrophage activationMonocyte-to-macrophage differentiation